Literature DB >> 23423887

GFP reporter screens for the engineering of amino acid degrading enzymes from libraries expressed in bacteria.

Olga Paley1, Giulia Agnello, Jason Cantor, Tae Hyun Yoo, George Georgiou, Everett Stone.   

Abstract

There is significant interest in engineering human amino acid degrading enzymes as non-immunogenic chemotherapeutic agents. We describe a high-throughput fluorescence activated cell sorting (FACS) assay for detecting the catalytic activity of amino acid degrading enzymes in bacteria, at the single cell level. This assay relies on coupling the synthesis of the GFP reporter to the catalytic activity of the desired amino acid degrading enzyme in an appropriate E. coli genetic background. The method described here allows facile screening of much larger libraries (10(6)-10(7)) than was previously possible. We demonstrate the application of this technique in the screening of libraries of bacterial and human asparaginases and also for the catalytic optimization of an engineered human methionine gamma lyase.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23423887      PMCID: PMC3910379          DOI: 10.1007/978-1-62703-293-3_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  21 in total

Review 1.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

2.  Pharmacokinetics, methionine depletion, and antigenicity of recombinant methioninase in primates.

Authors:  Zhijian Yang; Junhua Wang; Takayuki Yoshioka; Baoqiu Li; Quan Lu; Shukuan Li; Xinghua Sun; Yuying Tan; Shigeo Yagi; Eugene P Frenkel; Robert M Hoffman
Journal:  Clin Cancer Res       Date:  2004-03-15       Impact factor: 12.531

3.  Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy.

Authors:  Everett Stone; Lynne Chantranupong; Candice Gonzalez; Jamye O'Neal; Mridula Rani; Carla VanDenBerg; George Georgiou
Journal:  J Control Release       Date:  2011-10-06       Impact factor: 9.776

4.  Anticancer efficacy of methioninase in vivo.

Authors:  Y Tan; M Xu; H Guo; X Sun; T Kubota; R M Hoffman
Journal:  Anticancer Res       Date:  1996 Nov-Dec       Impact factor: 2.480

5.  Overexpression and large-scale production of recombinant L-methionine-alpha-deamino-gamma-mercaptomethane-lyase for novel anticancer therapy.

Authors:  Y Tan; M Xu; X Tan; X Tan; X Wang; Y Saikawa; T Nagahama; X Sun; M Lenz; R M Hoffman
Journal:  Protein Expr Purif       Date:  1997-03       Impact factor: 1.650

6.  Recombinant methioninase infusion reduces the biochemical endpoint of serum methionine with minimal toxicity in high-stage cancer patients.

Authors:  Y Tan; J Zavala; Q Han; M Xu; X Sun; X Tan; X Tan; R Magana; J Geller; R M Hoffman
Journal:  Anticancer Res       Date:  1997 Sep-Oct       Impact factor: 2.480

7.  Depletion of serum methionine by methioninase in mice.

Authors:  V K Lishko; O V Lishko; R M Hoffman
Journal:  Anticancer Res       Date:  1993 Sep-Oct       Impact factor: 2.480

8.  PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates.

Authors:  Zhijian Yang; Junhua Wang; Quan Lu; Jinbao Xu; Yoshinao Kobayashi; Tomoaki Takakura; Akio Takimoto; Takayuji Yoshioka; Changgen Lian; Chunmei Chen; Dongdong Zhang; Ying Zhang; Shukuan Li; Xinghua Sun; Yuying Tan; Shigeo Yagi; Eugene P Frenkel; Robert M Hoffman
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

9.  Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase.

Authors:  T Yoshioka; T Wada; N Uchida; H Maki; H Yoshida; N Ide; H Kasai; K Hojo; K Shono; R Maekawa; S Yagi; R M Hoffman; K Sugita
Journal:  Cancer Res       Date:  1998-06-15       Impact factor: 12.701

10.  Inhibition of acetohydroxy acid synthase by leucine.

Authors:  N Gollop; D M Chipman; Z Barak
Journal:  Biochim Biophys Acta       Date:  1983-10-17
View more
  1 in total

Review 1.  Actinomycetes: a repertory of green catalysts with a potential revenue resource.

Authors:  Divya Prakash; Neelu Nawani; Mansi Prakash; Manish Bodas; Abul Mandal; Madhukar Khetmalas; Balasaheb Kapadnis
Journal:  Biomed Res Int       Date:  2013-04-18       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.